200230 — Telcon RF Pharmaceutical Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Telcon RF Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-44,187	-23,207	-42,117	13,949	-26,500
Depreciation
Amortisation
Non-Cash Items	39,163	21,737	39,623	-12,194	26,714
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	3,778	-3,110	-3,877	-7,119	-2,985
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	3,150	-380	-2,090	-1,120	1,735
Capital Expenditures	-1,200	-5,813	-834	-1,898	-4,975
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-61,452	6,714	-7,055	-8,642	-39,625
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-62,653	900	-7,888	-10,539	-44,600
Financing Cash Flow Items	17.7	31	—	485	8.55
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	68,327	-1,891	-3,440	10,445	37,651
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	8,814	-1,346	-13,462	-1,214	-5,213